Bradycardia in a Man With Hypertension

Drutel, Robert; Payne, Judd R.; Glancy, D. Luke

doi:10.1016/j.amjcard.2019.06.034

Cited by 3 publications

(1 citation statement)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…3 A study by Drutel et al found that patients taking calcium channel blockers were likely to have a slow pulse and bradycardia as revealed by ECG. 14 Hypertension was the most common comorbidity in that study. Initially, we anticipated that hypertensive medications would affect the cardiac rhythm.…”

Section: Discussionmentioning

confidence: 55%

Bradycardia in Older Patients in a Single-Center Emergency Department: Incidence, Characteristics and Outcomes

Rujichanuntagul¹,

Sri‐on²,

Traiwanatham³

et al. 2022

OAEM

View full text Add to dashboard Cite

Objective This study aimed to explore data associated with the characteristics, incidence, and outcomes of older patients with symptomatic bradycardia presenting to the emergency department (ED). Methods We prospectively reviewed data of all patients aged 60 years and older who visited our ED with symptomatic bradycardia during 8AM-12PM between June 4, 2018, and June 10, 2019. The outcomes were the incidence of symptomatic bradycardia and adverse events (recurrent bradycardia, rate of ED revisits, subsequent hospitalization, mortality rate, and composite outcomes) at 30 days and 180 days. Results A total of 3297 patients visited the ED. Of these, 205 patients had symptomatic bradycardia. The incidence of symptomatic bradycardia was 6.2% (205/3297). One hundred fourteen patients (55.7%) were female, and the mean age was 74.9 (SD, 9) years. One-third of bradycardia patients (80 patients [39.0%]) were admitted to the hospital, 32 of whom because of unstable bradycardia. Ten of these 32 (30%) patients died during hospitalization from causes unrelated to bradycardia. One-third of unstable bradycardia patients had dyspnea (10/32 patients [31.3%]) followed by chest pain and altered mental status, respectively. ED revisit was the most common adverse event after 30 days (10.8%) and 180 days (20.3%). End-stage renal disease with hemodialysis was associated with adverse outcomes at 30 days (odds ratio, 2.34; 95% confidence interval, 1.30–20.87). Conclusion The incidence of symptomatic bradycardia among older adults was 6.2% in one urban ED. End-stage renal disease with hemodialysis was associated with adverse outcomes at 30 days. Larger studies should confirm this association and investigate methods of minimizing adverse outcomes.

show abstract

Section: Discussionmentioning

confidence: 55%